System Formulary Update
Pegcetacoplan (Empaveli)
Situation
Pegcetacoplan 1,080 mg/20 mL subcutaneous solution was approved for addition to the health system formulary at the October 2021 System Pharmacy and Therapeutics Committee meeting.
Background
The following medication was reviewed: Pegcetacoplan 1,080 mg/20 mL subcutaneous solution
Assessment/Recommendation
Change effective: Tuesday, November 30, 2021
System P&T voted to include the following products on the UNC Health Medication Formulary:
Note: Stock of this formulary product may vary at individual entities